Drug Eluting Stents: Friend or Foe? A Review of Cellular Mechanisms Behind the Effects of Paclitaxel and Sirolimus Eluting Stents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|9|6|554-566

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.9, Iss.6, 2008-07, pp. : 554-566

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypersensitivity with sirolimus and paclitaxel drug-eluting stents

By  

Reactions Weekly, Vol. 1, Iss. 1088, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Hypersensitivity with sirolimus and paclitaxel drug-eluting stents

By  

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Update on Sirolimus Drug-Eluting Stents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 4, 2004-02 ,pp. : 337-348

Bentham Science Publishers

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 225-228

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel- and sirolimus-eluting stents produce comparable clinical outcomes in the real world

By  

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite